ADC Therapeutics Non-GAAP EPS of -$0.25, revenue of $18.84M beats by $0.98M
Source: SeekingAlpha
2025-08-12 07:34:06 ET
More on ADC Therapeutics
- ADC Therapeutics SA (ADCT) Q1 2025 Earnings Call Transcript
- ADC Therapeutics SA 2025 Q1 - Results - Earnings Call Presentation
- ADC reports data from lymphoma trial, streamlines operations
- ADC Therapeutics announces $100M private financing
- Seeking Alpha’s Quant Rating on ADC Therapeutics
Read the full article on Seeking Alpha
For further details see:
ADC Therapeutics Non-GAAP EPS of -$0.25, revenue of $18.84M beats by $0.98M
ADC Therapeutics SA
NASDAQ: ADCT
ADCT Trading
-0.12% G/L:
$4.195 Last:
179,763 Volume:
$4.17 Open:
ADCT Latest News
March 10, 2026 07:30:00 am
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
ADCT Stock Data
$486,217,661
104,923,913
12.45%
40
N/A
Biotechnology & Life Sciences
Healthcare
CH
Epalinges
